| 000 | 01473 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250518024425.0 | ||
| 264 | 0 | _c20200224 | |
| 008 | 202002s 0 0 eng d | ||
| 022 | _a1535-4970 | ||
| 024 | 7 |
_a10.1164/rccm.201809-1738IM _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStyskel, Brett A | |
| 245 | 0 | 0 |
_aIbrutinib-associated Serositis in Mantle Cell Lymphoma. _h[electronic resource] |
| 260 |
_bAmerican journal of respiratory and critical care medicine _c06 2019 |
||
| 300 |
_ae43-e44 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aAdenine _xanalogs & derivatives |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Mantle-Cell _xdrug therapy |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdrug therapy |
| 650 | 0 | 4 | _aPiperidines |
| 650 | 0 | 4 |
_aPyrazoles _xadverse effects |
| 650 | 0 | 4 |
_aPyrimidines _xadverse effects |
| 650 | 0 | 4 |
_aSerositis _xchemically induced |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aLopez-Mattei, Juan | |
| 700 | 1 | _aJimenez, Carlos A | |
| 700 | 1 | _aStewart, John | |
| 700 | 1 | _aHagemeister, Fredrick B | |
| 700 | 1 | _aFaiz, Saadia A | |
| 773 | 0 |
_tAmerican journal of respiratory and critical care medicine _gvol. 199 _gno. 12 _gp. e43-e44 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1164/rccm.201809-1738IM _zAvailable from publisher's website |
| 999 |
_c29410133 _d29410133 |
||